{Reference Type}: Journal Article
{Title}: A 10-year in-depth follow-up of post-lingual hearing loss patients with Chinese domestic cochlear implants.
{Author}: Li J;Shi L;Du H;Chen W;Wang Q;Kang S;Yang S;
{Journal}: Acta Otolaryngol
{Volume}: 144
{Issue}: 3
{Year}: 2024 Mar 2
{Factor}: 1.698
{DOI}: 10.1080/00016489.2024.2355216
{Abstract}: <B>UNASSIGNED: </B>Follow-up of cochlear implant effectiveness is mainly focused on 3 years postoperatively, and studies with more than 5 years of observation are rare, especially for local Chinese brands.<BR><B>UNASSIGNED: </B>Nurotron (Chinese domestic cochlear implant brand) CI recipients who participated in the clinical trial in 2009 were followed-up for 10 years prospectively, providing data to guide doctors and patients.<BR><B>UNASSIGNED: </B>From December 2009 to April 2010, 57 subjects underwent Nurotron Venus CI surgery at multiple-centers, and were continued to be followed up and assessed at 1, 2, 3, 4, 5, and 10 years after switch on.<BR><B>UNASSIGNED: </B>All recipients were successfully implanted with CIs with no difficulty in subsequent use with one reported case of re-implantation at 9 years after implantation. The aided hearing thresholds were significantly improved at one month after switch on (p < 0.0001) and remained stable afterwards for 10 years. Speech recognition scores were significantly higher than pre-operative results (p < 0.05) and continued to improve till 3 years after switch on. At 10 years post-operation, most subjects had improved QOL scores in most sub-items.<BR><B>UNASSIGNED: </B>Nurotron Venus CI System provides long-term, stable results in hearing speech assistance capabilities and can improve the quality of life of CI recipients.